This is unpublished


Assistant Professor, Department of Dermatology
Sites of Practice
Fred Hutch Cancer Center


Fred Hutch Cancer Center  

Schedule Online

South Lake Union Clinic
825 Eastlake Ave E
Seattle, WA 98109



Dr. Park is a board-certified dermatologist from South Korea. Before joining Fred Hutchinson Cancer Center as a physician, Dr. Park worked as a clinical research fellow with the Nghiem Laboratory coordinating patient care and participating in research on Merkel cell carcinoma (MCC), a rare type of skin cancer. Dr. Park works with people who are experiencing various skin problems including skin cancers, treatment-related dermatitis, eczema, and general dermatology needs. She also has a special interest in hair disease, and dermatological procedures including intralesional therapy, where concentrated doses of a medication are injected directly into a skin lesion. The benefit of this type of therapy is that it allows us to treat a problem locally, minimizing side effects to the rest of the body.

Education & Training

MD, Seoul National University, Seoul, Korea (2010)

Residency in Dermatology, Seoul National University Hospital

Senior Clinical Research Fellowship, University of Washington

Research Interests

  • Merkel cell carcinoma
  • Melanoma

Clinical Interests

  • Merkel cell carcinoma
  • Melanoma
  • Skin cancer
  • Skin conditions related to cancer treatment
  • Hair disease



Selected Publications

Paul Nghiem, MD, PhD; Song Youn Park, MD. Less Toxic, More Effective Treatment—A Win-Win for Patients With Merkel Cell Carcinoma. JAMA Dermatol. 2019;155(11):1223-1224. doi:10.1001/jamadermatol.2019.2584

Nghiem P, Bhatia S, Lipson EJ, Sharfman WH, Kudchadkar RR, Brohl AS, Friedlander PA, Daud A, Kluger HM, Reddy SA, Boulmay BC, Riker AI, Burgess MA, Hanks BA, Olencki T, Margolin K, Lundgren LM, Soni A, Ramchurren N, Church C, Park SY, Shinohara MM, Salim B, Taube JM, Bird SR, Ibrahim N, Fling SP, Homet Moreno B, Sharon E, Cheever MA, Topalian SL. Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy. J Clin Oncol. 2019 Mar 20;37(9):693-702. doi: 10.1200/JCO.18.01896. Epub 2019 Feb 6.

Park SY, Hong JS, Roh JY, Lee JY, Kim DW, Yoon TJ, Sim WY, Lee KS, Kye YC, Lee AY, Kim MB, Cho S, Moon KC, Yang JM, Lee ES, Lee WS, Lee MG, Park SD, Won YH, Shin BS, Hong CK, Lee J, Yoon TY, Kim KJ, Ro YS, Kim KH, Eun HC. Epidemiological and Clinical Study of Scabies in Korea: Multicenter Retrospective Study. Korean J Dermatol. 2013 Sep;51(9):678-684.

Choi M, Kim MS, Park SY, Park GH, Jo SJ, Cho KH, Lee JW, Park KD, Shin HY, Kang HJ, Kwon O. Clinical characteristics of chemotherapy-induced alopecia in childhood. J Am Acad Dermatol. 2014 Mar;70(3):499-505.

Park SY, Na SY, Kim JH, Cho S, Lee JH. Iron plays a certain role in patterned hair loss. J Korean Med Sci. 2013 Jun;28(6):934-8.